These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3492994)

  • 1. Effect of ketorolac on Candida albicans ocular infection in rabbits.
    Fraser-Smith EB; Matthews TR
    Arch Ophthalmol; 1987 Feb; 105(2):264-7. PubMed ID: 3492994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of ketorolac on herpes simplex virus type one ocular infection in rabbits.
    Fraser-Smith EB; Matthews TR
    J Ocul Pharmacol; 1988; 4(4):321-6. PubMed ID: 3246566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of ketorolac on Pseudomonas aeruginosa ocular infection in rabbits.
    Fraser-Smith EB; Matthews TR
    J Ocul Pharmacol; 1988; 4(2):101-9. PubMed ID: 3262701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The quantitative effect of 0.5% ketorolac tromethamine solution and 0.1% dexamethasone sodium phosphate solution on postsurgical blood-aqueous barrier.
    Flach AJ; Kraff MC; Sanders DR; Tanenbaum L
    Arch Ophthalmol; 1988 Apr; 106(4):480-3. PubMed ID: 3355415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of ketorolac tromethamine solution 0.5% in reducing postoperative inflammation after cataract extraction and intraocular lens implantation.
    Flach AJ; Lavelle CJ; Olander KW; Retzlaff JA; Sorenson LW
    Ophthalmology; 1988 Sep; 95(9):1279-84. PubMed ID: 3062540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Results of a survey of patients with ocular allergy treated with topical ketorolac tromethamine.
    Raizman MB
    Clin Ther; 1995; 17(5):882-90. PubMed ID: 8595640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of ketorolac tromethamine in reducing postoperative inflammation: double-mask parallel comparison with dexamethasone.
    Flach AJ; Jaffe NS; Akers WA
    Ann Ophthalmol; 1989 Nov; 21(11):407-11. PubMed ID: 2619149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ketorolac tromethamine 0.5% ophthalmic solution in the treatment of moderate to severe ocular inflammation after cataract surgery: a randomized, vehicle-controlled clinical trial.
    Heier J; Cheetham JK; Degryse R; Dirks MS; Caldwell DR; Silverstone DE; Rosenthal A
    Am J Ophthalmol; 1999 Mar; 127(3):253-9. PubMed ID: 10088733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of ketorolac on phagocytosis of Candida albicans by peritoneal macrophages.
    Fraser-Smith EB; Matthews TR
    Immunopharmacology; 1988; 16(3):151-5. PubMed ID: 3075603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analgesic efficacy and safety of nonpreserved ketorolac tromethamine ophthalmic solution following radial keratotomy. Ketorolac Radial Keratotomy Study Group.
    Yee RW
    Am J Ophthalmol; 1998 Apr; 125(4):472-80. PubMed ID: 9559732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of benzalkonium chloride/EDTA on the ocular bioavailability of ketorolac tromethamine following ocular instillation to normal and de-epithelialized corneas of rabbits.
    Madhu C; Rix PJ; Shackleton MJ; Nguyen TG; Tang-Liu DD
    J Pharm Sci; 1996 Apr; 85(4):415-8. PubMed ID: 8901080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Double-masked, paired-comparison clinical study of ketorolac tromethamine 0.5% ophthalmic solution compared with placebo eyedrops in the treatment of seasonal allergic conjunctivitis.
    Tinkelman DG; Rupp G; Kaufman H; Pugely J; Schultz N
    Surv Ophthalmol; 1993; 38 Suppl():133-40. PubMed ID: 8236004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative assessment of postsurgical breakdown of the blood-aqueous barrier following administration of 0.5% ketorolac tromethamine solution. A double-masked, paired comparison with vehicle-placebo solution study.
    Flach AJ; Graham J; Kruger LP; Stegman RC; Tanenbaum L
    Arch Ophthalmol; 1988 Mar; 106(3):344-7. PubMed ID: 3345153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ocular bioavailability and tissue distribution of [14C]ketorolac tromethamine in rabbits.
    Ling TL; Combs DL
    J Pharm Sci; 1987 Apr; 76(4):289-94. PubMed ID: 3598886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of ketorolac tromethamine 0.5% ophthalmic solution for chronic aphakic and pseudophakic cystoid macular edema.
    Flach AJ; Dolan BJ; Irvine AR
    Am J Ophthalmol; 1987 Apr; 103(4):479-86. PubMed ID: 3551617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ketorolac tromethamine as compared with morphine sulfate for treatment of postoperative pain.
    O'Hara DA; Fragen RJ; Kinzer M; Pemberton D
    Clin Pharmacol Ther; 1987 May; 41(5):556-61. PubMed ID: 3568540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical evaluation of ketorolac tromethamine 0.5% ophthalmic solution for the treatment of seasonal allergic conjunctivitis.
    Ballas Z; Blumenthal M; Tinkelman DG; Kriz R; Rupp G
    Surv Ophthalmol; 1993; 38 Suppl():141-8. PubMed ID: 8236005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of topical nonsteroidal anti-inflammatory drugs on adenoviral replication.
    Gordon YJ; Araullo-Cruz T; Romanowski EG
    Arch Ophthalmol; 1998 Jul; 116(7):900-5. PubMed ID: 9682703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Asthma caused by topical application of ketorolac.
    Sitenga GL; Ing EB; Van Dellen RG; Younge BR; Leavitt JA
    Ophthalmology; 1996 Jun; 103(6):890-2. PubMed ID: 8643243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The morphine sparing effect of ketorolac tromethamine. A study of a new, parenteral non-steroidal anti-inflammatory agent after abdominal surgery.
    Gillies GW; Kenny GN; Bullingham RE; McArdle CS
    Anaesthesia; 1987 Jul; 42(7):727-31. PubMed ID: 3307518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.